PharmaNews.eu
  • Home
  • Business
  • R&D
  • EC
  • EMA
  • Events
  • Open Calls

Boehringer Ingelheim

Boehringer Ingelheim

Boehringer IngelheimThe Boehringer Ingelheim group is one of the world's 20 leading pharmaceutical companies. Headquartered in Ingelheim, Germany, it operates globally with 135 affiliates in 47 countries and almost 38,900 employees. Since it was founded in 1885, the family-owned company has been committed to researching, developing, manufacturing and marketing novel products of high therapeutic value for human and veterinary medicine. In 2007, Boehringer Ingelheim posted net sales of 10.9 billion euro while spending one fifth of net sales in its largest business segment Prescription Medicines on research and development. For more information please visit www.boehringer-ingelheim.com.

Boehringer Ingelheim RSS Channel

Filters
List of articles in category Boehringer Ingelheim
Title Published Date
Heinrich Wieland Prize goes to scientist for work on key structures in human fatty acid synthesis 03 November 2010
European Medicines Agency approves TWYNSTA® 14 October 2010
Boehringer Ingelheim Initiates Phase III Clinical Trial with Novel Oral Agent in Advanced Breast Cancer 20 September 2010
A new era for patients with atrial fibrillation - Dabigatran etexilate at the forefront 01 September 2010
Turnover and profit expectations fulfilled for first half-year results 06 August 2010
Positive Opinion for TWYNSTA®, Boehringer Ingelheim's new single pill combination hypertension treatment 27 July 2010
Fekrije Selimi wins Boehringer Ingelheim's FENS Award 2010 for Exceptional Research in Neuroscience 08 July 2010
Boehringer Ingelheim affirms safety of telmisartan with an analysis of 50,000 patients 15 June 2010
Boehringer Ingelheim launches Global Venture Fund to foster innovation in life sciences 06 April 2010
Boehringer Ingelheim and Priaxon announce a collaboration to research and develop novel treatments for cancer 20 January 2010
Boehringer Ingelheim initiates first Phase III clinical trial in Ovarian Cancer 04 January 2010
Milestone results in RE-COVER™ study - novel oral direct thrombin inhibitor dabigatran etexilate 16 December 2009
Major European regulatory milestone in cardiovascular protection for Micardis® (telmisartan) 30 November 2009
Boehringer Ingelheim and GlaxoSmithKline back EFA's call for urgent improvements in care for people with lung disease 20 November 2009
Heinrich Wieland Prize 2009 awarded for outstanding achievements in the synthesis of key natural products 03 November 2009
Boehringer Ingelheim Animal Health closes deal to acquire Animal Health Business from Pfizer 27 October 2009
Boehringer Ingelheim receives approval from the European Commission for Mirapexin®/Sifrol 15 October 2009
Access to HIV medication 08 October 2009
Boehringer Ingelheim's diabetes pipeline continues to advance 30 September 2009
Boehringer Ingelheim Animal Health enters into agreement to acquire certain assets of Fort Dodge Animal Health from Pfizer 23 September 2009

Page 4 of 5

  • Start
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • Next
  • End
  1. You are here:  
  2. Home
  3. Boehringer Ingelheim

About

  • Home
  • Terms and Conditions
  • Contact

Advertise

Top News Channels

  • Business
  • Research
  • EMA
  • Events

Follow us

Didn't we got you connected? If not, please note the following magic buttons:

  • Facebook
  • Twitter
  • RSS 2.0
  • Atom 1.0

Newsletter

Stay updated on the latest Pharma News. Subscribe now, it's free!

Copyright © 2025 PharmaNews.eu. All Rights Reserved.